Amneal Pharmaceuticals(DE:2DT)
€18.40+0.60 (+8.24%)
DE:2DT
Amneal Pharmaceuticals Revenue
€18.40
At close:+0.60 (+8.24%)
Amneal Pharmaceuticals (2DT) Revenue
2 Followers
Amneal Pharmaceuticals Revenue
Amneal Pharmaceuticals had a revenue of 862.68M in the quarter ending Sep 30, 2026, with 8.35%. This bring the company's revenue in the last twelve months to 3.20B, Increased 2.51%. In the fiscal year ending Dec 31, 2025, Amneal Pharmaceuticals had annual revenue of 3.02B with 8.05% growth.
- Revenue (ttm)
- 3.20B
- Revenue Growth
- 3.60%
- P/S Ratio
- 2.22
- Revenue/Employee
- EUR 346,984
- Employees
- 8,700
- Market Cap
- EUR 6.71B
Revenue Chart
Amneal Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.02B | 224.80M | 8.05% |
| Dec 31, 2024 | 2.79B | 400.35M | 16.73% |
| Dec 31, 2023 | 2.39B | 181.30M | 8.20% |
| Dec 31, 2022 | 2.21B | 118.64M | 5.67% |
| Dec 31, 2021 | 2.09B | 101.15M | 5.08% |
| Dec 31, 2020 | 1.99B | 366.15M | 22.51% |
| Dec 31, 2019 | 1.63B | -36.62M | -2.20% |
| Dec 31, 2018 | 1.66B | 629.34M | 60.88% |
| Dec 31, 2017 | 1.03B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.